Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
The authors of a recent study called for public awareness, screening, and accessible and early multidisciplinary care, as well as neighborhood-level public health interventions, to reduce the disproportionate burden of lower-extremity amputation in underserved communities.
Data from the Women's Health Initiative indicated that when 5% of energy intake from plant protein was substituted for animal protein, type 2 diabetes risk was estimated to decrease by approximately 21%.
This month's quiz asks readers to evaluate a 44-year-old woman with type 2 diabetes diagnosed 20 years ago and recent onset of burning pain in both feet.
A systematic review found that HbA1c levels were improved significantly by food supplementation with referral and diabetes support, financial incentives with education and skills training, housing relocation with counseling support, and the integration of nonmedical interventions into medical care.